Cargando…
Examination and characterisation of the effect of amitriptyline therapy for chronic neuropathic pain on neuropeptide and proteomic constituents of human cerebrospinal fluid
INTRODUCTION: Amitriptyline is prescribed to reduce the intensity of chronic neuropathic pain. There is a paucity of validated in vivo evidence in humans regarding amitriptyline’s mechanism of action. We examined the effect of amitriptyline therapy on cerebrospinal fluid (CSF) neuropeptides and prot...
Autores principales: | Royds, Jonathan, Cassidy, Hilary, Conroy, Melissa J., Dunne, Margaret R., Lysaght, Joanne, McCrory, Connail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474617/ https://www.ncbi.nlm.nih.gov/pubmed/34589721 http://dx.doi.org/10.1016/j.bbih.2020.100184 |
Ejemplares similares
-
The Proteomics of Intrathecal Analgesic agents for Chronic Pain
por: Moore, David M., et al.
Publicado: (2017) -
The role of T-lymphocytes in neuropathic pain initiation, development of chronicity and treatment
por: Galvin, DA, et al.
Publicado: (2021) -
Action of mefloquine/amitriptyline THN101 combination on neuropathic mechanical hypersensitivity in mice
por: Letellier, Baptiste, et al.
Publicado: (2021) -
The characterisation of the virion RNA of avian Infectious Bronchitis Virus
por: Macnaughton, Malcolm R., et al.
Publicado: (1977) -
Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline
por: Kopsky, David J., et al.
Publicado: (2012)